跳至主要内容
临床试验/ISRCTN41194672
ISRCTN41194672进行中(未招募)未知

A prospective observational study to measure platelet inhibition by aspirin administered for reactive thrombocytosis in Pseudomyxoma Peritonei patients

Hampshire Hospitals NHS Foundation Trust0 个研究点目标入组 156 人开始时间: 2023年2月2日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
156

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients >18 years of age
  • 2. Diagnosis of Pseudomyxoma Peritonei
  • 3. Patients undergoing CRS and HIPEC
  • 4. Post-operative platelet count of >1000 x 10^9/L

排除标准

  • 1. Patients <18 years of age
  • 2. Having CRS and HIPEC for other conditions apart from Pseudomyxoma Peritonei
  • 3. Allergic to aspirin
  • 4. On other antiplatelet or drugs that affect platelet function e.g. NSAIDs
  • 5. Ischaemic vascular events, percutaneous coronary intervention, or coronary artery bypass within the last 12 months

研究者

相似试验